Analystreport

Nightstar Therapeutics PLC (NASDAQ: NITE) had its "positive" rating re-affirmed by analysts at Leerink Swann. They now have a $35.00 price target on the stock, up previously from $30.00.

NIGHTSTAR THERAPEUTICS PLC AMERICAN DEPOSITARY SHA  (NITE) 
Last nightstar therapeutics plc american depositary sha earnings: 11/13 01:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nightstartx.com/investor-relations